Solid Biosciences Inc. — Director's Dealing 2023

Jun 9, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2023-05-02

Reporting Person: Ganot Ilan (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-05-02	Common Stock	M	1553	—	Acquired	4640	Indirect
2023-05-02	Common Stock	S	487	$4.8541	Disposed	4153	Indirect
2023-06-02	Common Stock	M	1583	—	Acquired	87758	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-05-02	Restricted Stock Units	$	M	1553	Disposed		Common Stock (1553)	Indirect
2023-06-02	Restricted Stock Units	$	M	1583	Disposed		Common Stock (1583)	Direct
2023-06-06	Director Stock Option (Right to Buy)	$6.37	A	9650	Acquired	2033-06-06	Common Stock (9650)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	19394	Indirect

Footnotes

F1: Restricted stock units convert into common stock on a one-for-one basis.

F2: Includes 1,709 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 31, 2023.

F3: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1).

F4: Represents 83,716 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship.

F5: Represents 19,394 shares held by Adam Ganot and Annie Ganot, and their successors, as the trustees for the Ilan Ganot 2017 Irrevocable Trust dated March 3, 2017.

F6: The restricted stock units were granted on May 2, 2022 and vest in two equal annual installments beginning on the first anniversary of the grant date.

F7: On December 2, 2022 (the "Grant Date"), Mr. Ganot was granted 6,333 restricted stock units, vesting in equal quarterly installments with the first installment vesting three months from the Grant Date and the final installment vesting date being the date that is 12 months from the Grant Date; provided that in the event of a change in control the restricted stock units shall accelerate in full.

F8: This option was granted on June 6, 2023 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.